What The EMA Can Teach HTA Bodies About Joint Clinical Assessments

EU-level joint clinical assessments conducted under the Health Technology Assessment Regulation need to be more flexible when it comes to evidence requirements, according to experts speaking at a gene and cell therapy conference.

The EMA'S approach to non-traditional studies should be echoed in the joint clinical assessment process. (Shutterstock)

More from Advanced Technologies

More from R&D